11 reports

Filgrastim – Introduction ##.

  • Biological Therapy
  • Filgrastim
  • World
  • Demand
  • filgrastim
  • filgrastim
  • Filgrastim
  • Asia
  • Japan
  • Amgen Inc.
  • Kyowa Hakko Kirin Co., Ltd.
  • FILGRASTIM - DRUG PROFILE
  • FILGRASTIM - DRUG PROFILE
  • Biosimilar
  • Filgrastim
  • United States
  • Product Initiative
  • Coherus BioSciences, Inc.
  • FILGRASTIM - DRUG PROFILE
  • FILGRASTIM - DRUG PROFILE
  • Chemotherapy
  • Filgrastim
  • United States
  • Product Initiative
  • GlycoMimetics, Inc.
  • Filgrastim: Biosimilar Products in South Korea
  • Filgrastim: Biosimilar Products in China & Taiwan - 1/2
  • Filgrastim
  • G-CSF
  • Europe
  • United States
  • Amgen Inc.
  • FILGRASTIM - DRUG PROFILE
  • FEBRILE NEUTROPENIA - PIPELINE BY BIOGENOMICS LIMITED, H1 2016
  • Filgrastim
  • Therapy
  • United States
  • World
  • Product Initiative
  • FILGRASTIM - DRUG PROFILE
  • FILGRASTIM - DRUG PROFILE
  • Chemotherapy
  • Filgrastim
  • United States
  • World
  • Product Initiative
  • filgrastim alone or in combination has the highest number of neutropenia ongoing clinical trials.
  • Clinical Trial profile. 13 Trial Title
  • Blood Disease
  • Filgrastim
  • World
  • Product Initiative
  • Amgen Inc.
  • Target
  • Clinical Trial profile. 37 Trial Title
  • Chemotherapy
  • Filgrastim
  • Therapy
  • World
  • Product Initiative
  • Clinical Trial profile. 153 Trial Title

filgrastim ## cyclophosphamide ## docetaxel (piperacillin sodium + tazobactam sodium) (piperacillin + tazobactam) Total Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2017 2017 trials are taken as of August 2017 ##

  • Clinical Trial
  • Filgrastim
  • World
  • Product Initiative
  • Amgen Inc.
  • Clinical Trial profile. 115 Trial Title
  • Clinical Trial profile. 13 Trial Title
  • Blood Disease
  • Blood Supply
  • Filgrastim
  • World
  • Product Initiative